November 20, 2015
Clozapine REMS deadlines for prescribers and pharmacies extended
The prescriber certification deadline for new Clozapine REMS Program has been extended from November 23 to December 14. Due to…
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
November 20, 2015
FDA advices not to use XForMan Plus
The Food and Drug Administration (FDA) has issued a notice in which it advises consumers not to purchase or use XForMan Plus,…
November 19, 2015
FDA nods to Narcan nasal spray-used to stop opioid overdose
The U.S. Food and Drug Administration approved Narcan nasal spray on Wednesday. Narcan is the first FDA-approved nasal spray version of…
November 19, 2015
Sanofi CEO: Health must be part of the Climate debate
Sanofi will participate to Solutions COP21, the United Nations conference on climate change, as an official partner, a public exhibition in Paris.
November 19, 2015
American Medical Association calls for ban on direct to consumer advertising of RX drugs and medical devices
The United States and New Zealand are the only two countries in the world that allow direct-to-consumer advertising of prescription drugs.
November 18, 2015
Health Canada to review Janssen’s NDS for daratumumab for Multiple Myeloma
Health Canada has accepted for review Janssen’s new drug submission (NDS) for daratumumab for treatment of Multiple Myeloma.
November 18, 2015
UK cost watchdog turns down Amgen’s new cholesterol drug
Amgen’s new injectable cholesterol drug Repatha has been turned down for use on Britain’s state health service, underscoring a worldwide debate about the value of such pricey medicines.
November 18, 2015
World Antibiotic Awareness Week; help patients get smart about antibiotic use
US Food and Drug Administration (FDA) has issued a video in which it suggest to pharmacists how to encourage the appropriate use of antibiotics.
November 18, 2015
FDA grants Breakthrough Therapy designation to Avelumab for treating Merkel cell carcinoma
The US Food and Drug Administration (FDA) has granted avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Breakthrough…
November 18, 2015
Anavex prepares for regulatory filings based on FDA guidance
Anavex is moving forward with the development program for ANAVEX 2-73 for the treatment of Alzheimer’s disease in a…